The Puncturable Atrial Septal Defect Occluder Trial (the PASSER Trial)

Status Recruiting

Clinical Trial Summary

A multicenter, randomized, parallel-controlled clinical trial to evaluate the efficacy and safety of a new atrial septal defect occluder, ReAces®, and delivery system for the treatment of atrial septal defect occlusion. Compared with the traditional atrial septal occluder, this new atrial septal occluder supports re-puncture after occluder implantation. Thus those patients who have undergone atrial septal defect closure with the novel device may be eligible for future radiofrequency ablation of atrial fibrillation or mitral valve intervention. The trial is expected to enroll 128 patients who will be randomly assigned to the test group or control group in a 1:1 ratio. Patients in test group will received ReAces occluder，and the others the regular occluder.The experiment is scheduled to enroll 128 patients who will be randomly allocated to one of two groups: test or control. Patients in the test group will receive a ReAces occluder, while those in the control group will receive a standard occluder.The safety and efficacy of the two groups at 1 year after surgery will be compared.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05371366
Study type	Interventional
Source	Shanghai Zhongshan Hospital
Contact	Wenzhi Pan, Dr
Phone	+86 13774475922
Email	peden@sina.com
Status	Recruiting
Phase	N/A
Start date	April 22, 2022
Completion date	April 22, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01120964` - Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol	Phase 1/Phase 2
Active, not recruiting	`NCT04950192` - Philips Intracardiac Echocardiography (ICE) Clinical Registry
Completed	`NCT02621528` - Lifetech CeraFlex™ Post-Market Surveillance Study	N/A
Recruiting	`NCT04291898` - Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study	N/A
Terminated	`NCT01773252` - Right to Left Cardiac Shunt Detection	Phase 3
Not yet recruiting	`NCT05887700` - Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
Not yet recruiting	`NCT06344494` - Cardiac Interventional ICE Imaging Trial	N/A
Recruiting	`NCT06298344` - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease	Early Phase 1
Recruiting	`NCT06431178` - General Anesthesia Versus Sedation By Dexmedetomidine and Ketamine With Local Infiltration for Percutaneous Transcatheter Closure of Atrial Septal Defect in Pediatric Patients	N/A
Active, not recruiting	`NCT04105595` - Post Market Registry of the CBSO
Recruiting	`NCT05688670` - Regional Anesthesia Following Pediatric Cardiac Surgery	Phase 4
Active, not recruiting	`NCT02739087` - Radiation-Free Heart Catheterization Using MRI	N/A
Recruiting	`NCT02097758` - Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect	N/A
Completed	`NCT02985684` - Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs	N/A
Completed	`NCT06139679` - Improvement In Left Ventricular Diameter After Closure Of ASD With Fenestrated Patch: A Cross-sectional Study
Recruiting	`NCT05540769` - Holter and ECG Changes After Transcatheter Closure Of ASD In Children	N/A
Recruiting	`NCT04096924` - A Prospective Randomized Multicenter Trial of the Guidewire for Echo-guided Interventions	N/A
Enrolling by invitation	`NCT02766569` - International Registry for ASD Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients	N/A
Completed	`NCT02957201` - The Effect on EPCs by Successful Cardiac Occlusion Device Implantation	N/A
Recruiting	`NCT02453451` - The Effect of the Hole in the Cardiac Septum Developed by the MitraClip Procedure on the Blood Flow Mechanics	N/A